Focal Healthcare

What Focal Healthcare does

Focal Healthcare is a privately held medical equipment manufacturer founded in 2014 and headquartered in Toronto, Canada. The company designs and develops fusion MRI and BX (biopsy) semi-robotic systems, which are used in image-guided prostate and likely other targeted biopsy procedures. Its product line integrates MRI imaging with semi-robotic needle guidance to enable precision tissue sampling, placing Focal Healthcare in the niche of image-fusion interventional oncology equipment that competes with larger urology imaging and robotics incumbents.

The company's business model appears to follow a capital equipment sales motion typical of medical device OEMs, with sales to hospitals, urology clinics, and imaging centers. Pricing is not publicly disclosed. With 11-50 employees, Focal Healthcare is a small specialist player. The company has limited publicly verifiable footprint: the only external capital event recorded is a 2019 funding round involving Sunhope Capital (an investor with Asia-Pacific ties), and there are no disclosed customer logos, distribution partnerships, regulatory milestones, or revenue figures in the source data. The company website and detailed product/management information were not accessible at the time of data collection, which materially limits due diligence depth.

Overall, Focal Healthcare presents as a focused, early-commercialization-stage medical device firm in a technically demanding niche. The strategic intent inferred from the product line and the 2019 Sunhope Capital involvement is dual: defend a specialized technology position in MRI-fusion biopsy while exploring cross-border (potentially China/Asia) commercialization pathways. However, the absence of any post-2019 strategic events, leadership disclosures, or growth signals in the available data represents a significant information gap that any prospective investor would need to close through primary outreach.

Name

Focal Healthcare

Website

https://focalhealthcare.com

Company type

Private

Founded year

2014

Headcount range

11–50 employees

Short description

Focal Healthcare is a Toronto-based medical equipment manufacturer (founded 2014) that designs fusion MRI and BX semi-robotic systems for image-guided biopsy procedures, serving hospitals and urology clinics.

Ownership category

akta.pro rank

Product category

Medical Imaging Equipment

NAICS

Surgical and Medical Instrument Manufacturing (339112), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF)

akta.pro secondary industries

Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence) (HLAHADAH), Medical Imaging AI (HDAAAEAH)

Keywords

• Medical imaging equipment
• MRI fusion systems
• Robotic biopsy systems
• Prostate cancer diagnostics
• Surgical robotics

Headquarters

HQ city

Toronto

HQ country

Canada

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations

Core offering

Focal Healthcare develops and designs fusion MRI and BX semi-robotic systems for medical imaging and image-guided biopsy procedures. The company manufactures capital medical equipment that combines MRI fusion imaging with semi-robotic precision for diagnostic and interventional applications, primarily in urology workflows such as prostate biopsy.

Differentiator

Problem solved

Functional benefit

Products and services

• Fusion MRI system A fusion MRI medical imaging system designed to combine MRI imaging with procedural guidance for diagnostic and interventional use, sold to hospitals and specialty clinics performing image-guided urological procedures.
• BX semi-robotic system A semi-robotic biopsy system designed to provide precision targeting for tissue sampling procedures, intended for clinical use in urology workflows such as prostate biopsy, and sold to hospitals and specialty clinics.

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves1 record

Expansion highlights2 records

Direct peers

• Koelis: Koelis is a France-based medical device company specializing in MRI-ultrasound fusion systems for targeted prostate biopsy. It is the closest direct competitor to Focal Healthcare's fusion BX semi-robotic platform, serving the same urology workflow with similar image-guidance technology.

Broad incumbents

• Siemens Healthineers: Siemens Healthineers sells the UroFusion / syngo Fusion applications and broad urology imaging workflows. As a global imaging and medtech incumbent, it competes for the same hospital budgets as Focal Healthcare with the ability to bundle software with MRI and ultrasound hardware.
• GE HealthCare: GE HealthCare provides MRI, ultrasound, and image-guidance solutions used in prostate biopsy workflows. As a broad medtech incumbent with deep hospital relationships, it represents an indirect but material competitive force for Focal Healthcare's fusion-biopsy system.
• Elekta: Elekta is a global medtech incumbent in radiation therapy and urology workflows, with products and services that touch the prostate cancer care pathway. While not a direct fusion-biopsy competitor, it competes for hospital capital and is a relevant strategic adjacency for Focal Healthcare.
• Philips (Invivo / Eigen): Philips offers the Invivo DynaCAD and UroNav fusion biopsy systems (built on the acquired Eigen platform), a leading MRI-TRUS fusion solution in the US. As a global imaging and medtech incumbent, Philips bundles fusion biopsy with its MRI installed base, competing directly with Focal Healthcare's hospital-facing offering.
• Hitachi (Real-time Virtual Sonography): Hitachi's Real-time Virtual Sonography (RVS) provides MRI-ultrasound fusion for prostate biopsy, often integrated with Hitachi ultrasound systems. It overlaps with Focal Healthcare's fusion-biopsy value proposition and is a broad-incumbent alternative for hospitals standardized on Hitachi imaging.

Emerging players

• Biobot Surgical: Biobot Surgical develops the iSR'obot Mona Lisa prostate biopsy platform and related fusion-biopsy technologies, with a focus on Asian markets. It is an emerging specialist directly comparable to Focal Healthcare in robotic MRI-targeted biopsy.
• MedCom (BiopSee): MedCom offers BiopSee, a stereotactic prostate biopsy system combining ultrasound and MRI/CT fusion for targeted biopsy. It is an emerging specialist with product overlap to Focal Healthcare's fusion BX system, primarily sold in European and select global markets.
• iSR'obot (Mona Lisa): iSR'obot markets the Mona Lisa robotic system for MRI-targeted prostate biopsy, a direct technological analog to Focal Healthcare's semi-robotic fusion BX system. It is an emerging specialist competing in the same niche, primarily in Europe and Asia.
• MIM Software: MIM Software develops medical imaging analysis and fusion software used in radiology and image-guided interventions, including prostate. It is an emerging software-focused player overlapping with the imaging-registration and AI components of Focal Healthcare's platform.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights4 records

Customer concentration

• Xx.com/focalhealthcare

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Focal Healthcare